Watchlist Price Alert

Evoke Pharma Inc. (EVOK)

NASDAQ: EVOK · Real-Time Price · USD

3.55

-0.06 (-1.71%)

At close: May 30, 2025, 3:25 PM

3.55

0.00%

After-hours: May 30, 2025, 04:00 PM EDT

-1.71% (1D)

Bid	3.11
Market Cap	5.3M
Revenue (ttm)	11.59M
Net Income (ttm)	-5.08M
EPS (ttm)	-1.26
PE Ratio (ttm)	-2.82
Forward PE	2.42
Analyst	n/a

Ask	4.48
Volume	3,080
Avg. Volume (20D)	20,680
Open	3.50
Previous Close	3.61
Day's Range	3.33 - 3.55
52-Week Range	1.94 - 12.32
Beta	0.15

About EVOK

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol EVOK

Website n/a

Full Company Profile

Why Price Moved

5 months ago

+24.77%

Evoke Pharma shares are trading higher after the c... Unlock content with Pro Subscription

7 months ago

+33.58%

Evoke Pharma shares are trading higher after the company announced the presentation of GLP-1 data for users with diabetic gastoparesis using GIMOTI and showed statistically significant improvements.

News

1 month ago · proactiveinvestors.co.uk

evoke makes a steady exit from the Q1 starting gate

Evoke PLC (LSE:EVOK) has kicked off 2025 with a steady start, reporting first-quarter revenue of £437.00 million—up 1% on last year and pretty much bang on with what it had guided. So far this year, r...

2 months ago · proactiveinvestors.co.uk

William Hill owner Evoke falls at the first-quarter update

Evoke PLC (LSE:EVOK) shares plummeted 18% after the William Hill owner reported annual results in line with expectations but revealed slower growth at the start of 2025. Results for the past calendar...

2 months ago · seekingalpha.com

Evoke Pharma, Inc. (EVOK) Q4 2024 Earnings Call Transcript

Evoke Pharma, Inc. (NASDAQ:EVOK ) Q4 2024 Earnings Conference Call March 13, 2025 4:30 PM ET Company Participants Daniel Kontoh-Boateng – DKB Partners Matt D'Onofrio – Chief Executive Officer Chris Qu...